IP Verse

Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein Composition - EP2809773

The patent EP2809773 was granted to DR Reddys Laboratories on Sep 2, 2020. The application was originally filed on Jan 18, 2013 under application number EP13743691A. The patent is currently recorded with a legal status of "Revoked".

EP2809773

DR REDDYS LABORATORIES
Application Number
EP13743691A
Filing Date
Jan 18, 2013
Status
Revoked
Jan 13, 2023
Grant Date
Sep 2, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BREUERJun 2, 2021BREUER FRIEDRICH HAHNER PATENTANWALTE PARTG MBBADMISSIBLE
D YOUNGJun 2, 2021D YOUNGADMISSIBLE
OETKEJun 2, 2021WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE
STRAWMANJun 2, 2021MEWBURN ELLISADMISSIBLE
MAIWALDJun 1, 2021MAIWALDADMISSIBLE

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2011053223
DESCRIPTIONUS5821337
DESCRIPTIONUS7972810
DESCRIPTIONWO2011019622
DESCRIPTIONWO2011127322
INTERNATIONAL-SEARCH-REPORTUS2011053223
INTERNATIONAL-SEARCH-REPORTWO2007070315
OPPOSITIONEP3434760
OPPOSITIONIN334CHE2012
OPPOSITIONUS5096816
OPPOSITIONUS6048728
OPPOSITIONWO2007070315
OPPOSITIONWO2008008360
OPPOSITIONWO2008109410
OPPOSITIONWO2008128227
OPPOSITIONWO2010138502
OPPOSITIONWO2010141855
OPPOSITIONWO2011019622
OPPOSITIONWO2011127322
OPPOSITIONWO2011134919
OPPOSITIONWO2012149197
OPPOSITIONWO2013114245
SEARCHWO2011019622
SEARCHWO2011127322

Non-Patent Literature (NPL) Citations (65) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BORYS M.C.LINZER, D.I.H., PAPOUTSAKIS, BIO/technology, (19930000), vol. 11, pages 720 - 724-
DESCRIPTION- BURDA, P.AEBI M., Biochimica et Biophysica Acta (BBA) General Subjects, (19990000), vol. 1426, no. 2, pages 239 - 257-
DESCRIPTION- CROWELL CKGRAMPP GEROGERS GNMILLER JSCHEINMAN RI., Biotechnol Bioeng., (20070000), vol. 96, pages 538 - 549-
DESCRIPTION- GEOFFREY, R. G., Analytical Biochemistry, (19960000), vol. 240, pages 210 - 226-
DESCRIPTION- HANRUE IMAI-NISHIYA, BMC Biotechnology, (20070000), vol. 7, page 84-
DESCRIPTION- J.lmnnmology, (19980000), vol. 160, pages 3393 - 3402-
DESCRIPTION- KAUFMAN, H.MAZUR X.FUSSENEGGER, M.BAILEY, J.E., Biotechnol Bioeng., (19990000), vol. 63, pages 573 - 578-
DESCRIPTION- MARINO, K., Nature Chemical Biology, (20100000), vol. 6, pages 713 - 723-
DESCRIPTION- MOORE AMERCER JDUTINA GDONAHUE CJBAUER KDMATHER JPETCHEVERRY TRYLL T, Cytotechnology, (19970000), vol. 23, pages 47 - 54-
DESCRIPTION- MORI K, Cytotechnology, (20070000), vol. 55, no. 2-3, pages 109 - 114-
DESCRIPTION- MUTHING JKEMMINER SECONRADT HSSAGI DNIMTZ MKARST UPETER- KATALINIC J., Biotechnol Bioeng, (20030000), vol. 83, pages 321 - 334-
DESCRIPTION- PACIS, E.YU, M.AUTSEN, J.BAYER, R.LI, F., Biotechnology and Bioengineering, (20110000), vol. 108, pages 2348 - 2358-
DESCRIPTION- RUHAAK L.R., Anal Bioanal Chem, (20100000), vol. 397, pages 3457 - 3481-
DESCRIPTION- SCHWARZ, F.AEBI M., Current Opinion in Structural Biology, (20110000), vol. 21, pages 576 - 582-
DESCRIPTION- SHIELDS RL, J Biol Chem, (20020000), vol. 277, no. 30, pages 26733 - 26740-
DESCRIPTION- TRUMMER, E.FAULAND, K., Biotechnol Bioeng., (20060000), vol. 94, pages 1045 - 1052-
DESCRIPTION- WRIGHTMORRISON, J. Exp. Med., (19940000), vol. 180, pages 1087 - 1096-
DESCRIPTION- WUHRER M. et al., Journal of Chromatography B, (20050000), vol. 825, no. 2, pages 124 - 133-
DESCRIPTION- YOON S.K.SONG, J. Y.LEE, G.M., Biotechnol Bioeng., (20030000), vol. 82, pages 289 - 298-
DESCRIPTION- ZHOU Q. et al., Biotechnol Bioeng, (20080000), vol. 99, no. 3, pages 652 - 665-
INTERNATIONAL-SEARCH-REPORT- YAMANE O. ET AL., "Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity", BIOTECHNOLOGY AND BIOENGINEERING, (20040905), vol. 87, no. 5, pages 614 - 622, XP002983153
INTERNATIONAL-SEARCH-REPORT- KATSUHIRO M. ET AL., "Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA", BIOTECHNOLOGY AND BIOENGINEERING, (20041230), vol. 88, no. 7, pages 901 - 908, XP002361932
INTERNATIONAL-SEARCH-REPORT- PACIS E. ET AL., "Effects of cell culture conditions on antibody N-linked glycosylation -- what affects high mannose 5 glycoform", BIOTECHNOLOGY AND BIOENGINEERING, (20111010), vol. 108, no. 10, pages 2348 - 2358, XP055080567
OPPOSITION- Anonymous, "Cytiva Hyclone CDM4CHO Media Liquid", Thermo Fisher datasheet, (20210530), pages 1 - 1, XP055951827-
OPPOSITION- Anonymous, "Mammalian Cell Biotechnology- A practical approach", IRL Press, (19910101), pages 8 - 15, XP055951810-
OPPOSITION- Anonymous, "Printout DMEM/F-12", Thermo Fisher Scientific, (20210530), no. 11320033, pages 1 - 3, XP055951806-
OPPOSITION- BURGENER A. et al., "Medium Development", Cell Culture Tech- nology for Pharmaceutical and Cell - Based Therapies, (20060000), pages 41 - 79, XP055454641-
OPPOSITION- Christopher A. Sellick, "Optimizing CHO Cell Culture Conditions", (20091001), URL: https://www.genengnews.com/magazine/120/optimizing-cho-cell-culture-conditions/, (20201109), XP055748367-
OPPOSITION- Hauser Hansjorg, Wagner, "Mammalian cell biotechnology in protein production", RolandMammalian Cell Biotechnology in Protein Production, (19970101), pages 244 - 249, XP055951823-
OPPOSITION- RAJU T.S., "Glycosylation variations with expression systems and their im- pact on biological activity of therapeutic immunoglobulins", BioProcess In- ternational, (20030000), vol. 1, no. 4, pages 44 - 53, XP001247475-
OPPOSITION- RESTELLI V, BUTLER M, "THE EFFECT OF CELL CULTURE PARAMETERS ON PROTEIN GLYCOSYLATION", CELL ENGINEERING, XX, XX, XX , (20020101), vol. 03, pages 61 - 92, XP001203473-
OPPOSITION- SPEARMAN M. et al., "The role of glycosylation in therapeutic antibodies. In: Al-Rubeai M. (eds) Antibody Expression and Production", Cell Engineer- ing, (20110000), vol. 7, no. Chapter 12, pages 251 - 292, XP055240498-
OPPOSITION- Ying Quing Yu, Ahn Joomi, Gilar Martin, "Trastuzuman Glycan Batch-to-Batch Profiling using a UPLC/FLR/Mass Spectrometry Platform", United States, United States , (20100601), pages 1 - 8, URL: http://www.waters.com/webassets/cms/library/docs/720003576en.pdf, (20180207), XP055448715-
OPPOSITION- YAMANE-OHNUKI N. ET AL., "Establishment of FUT8 knockout chinese hanster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20040806), vol. 87, no. 5, doi:10.1002/bit.20151, ISSN 0006-3592, pages 614 - 622, XP002983758
OPPOSITION- Katsuhiro Mori; Reiko Kuni‐Kamochi; Naoko Yamane‐Ohnuki; Masako Wakitani; Kazuya Yamano; Harue Imai; Yutaka Kanda; Rinpei Niwa; Shigeru Iida; Kazuhisa Uchida; Kenya Shitara; Mitsuo Satoh, "Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20041028), vol. 88, no. 7, doi:10.1002/bit.20326, ISSN 0006-3592, pages 901 - 908, XP071151692
OPPOSITION- Christopher K. Crowell; Gustavo E. Grampp; Gary N. Rogers; Janis Miller; Robert I. Scheinman, "Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20060825), vol. 96, no. 3, doi:10.1002/bit.21141, ISSN 0006-3592, pages 538 - 549, XP071134465
OPPOSITION- CROWELL C.K. et al., "Amino acid and manganese supplementation modu- lates the glycosylation state of erythropoietin in a CHO culture system", Biotechnol Bioeng., (20070000), vol. 96, no. 3, pages 538 - 549, XP002454615
OPPOSITION- CROWELL et al., "Amino Acid and Manganese Supplementation Modulates the Glycosylation State of Erythropoietin in a CHO Culture System", Biotechnol. Bioeng., (20060000), vol. 96, no. 3, doi:10.1002/bit.21141, pages 538 - 549, XP002457773
OPPOSITION- Zhou Quin; Shankara Srinivas; Roy Andre; Qiu Huawei; Estes Scott; McVie-Wylie Alison; Culm-Merdek Kerry; Park Anna; Pan Clark; Edmunds, "Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20080201), vol. 99, no. 3, doi:10.1002/bit.21598, ISSN 0006-3592, pages 652 - 665, XP009137262
OPPOSITION- Jong Hyun Nam, Fuming Zhang, Myriam Ermonval, Robert J. Linhardt, Susan T. Sharfstein, "The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells", Biotechnology and Bioengineering, Wiley ¬etc.|, (20080815), vol. 100, no. 6, doi:10.1002/bit.21853, ISSN 00063592, pages 1178 - 1192, XP055053835
OPPOSITION- GAWLITZEK et al., "Identification of Cell Culture Conditions to Control N-glycosylation Site-Occupancy of Recombinant Glycoproteins Expressed in CHO Cells", Biotechnol. Bioeng., (20090000), vol. 103, no. 6, doi:10.1002/BIT.22348, pages 1164 - 1175, XP002688571
OPPOSITION- Martin Gawlitzek, Michael Estacio, Tobias Fürch, Robert Kiss, "Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells.", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20090409), vol. 103, no. 6, doi:10.1002/BIT.22348, ISSN 0006-3592, pages 1164 - 1175, XP002688571
OPPOSITION- GRAMER et al., "Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose", Biotechnol. Bioeng., (20110000), vol. 108, no. 7, doi:10.1002/bit.23075, pages 1591 - 1602, XP002688515
OPPOSITION- Gramer M J, Eckblad J J, Donahue R, Brown J, Shultz C, Vickerman K, Priem P, van den Bremer E T, Gerritsen J, van Berkel P H, "Modulation of Antibody Galactosylation Through Feeding of Uridine, Manganese Chloride, and Galactose", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20110701), vol. 108, no. 7, doi:10.1002/bit.23075, ISSN 0006-3592, pages 1591 - 1602, XP002688515
OPPOSITION- GRAMER M.J. et al., "Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose", Biotechnol Bioeng., (20110000), vol. 108, doi:10.1002/bit.23075, pages 1591 - 602, XP002688515
OPPOSITION- Michael J. Gramer; Jackie J. Eckblad; Ruth Donahue; Joseph Brown; Carrie Shultz; Kent Vickerman; Patrick Priem; Ewald T.J. van den Bremer; Jolanda Gerritsen; Patrick H.C. van Berkel, "Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20110218), vol. 108, no. 7, doi:10.1002/bit.23075, ISSN 0006-3592, pages 1591 - 1602, XP071113776
OPPOSITION- Efren Pacis; Marcella Yu; Jennifer Autsen; Robert Bayer; Feng Li, "Effects of cell culture conditions on antibody N‐linked glycosylation—what affects high mannose 5 glycoform", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20110524), vol. 108, no. 10, doi:10.1002/bit.23200, ISSN 0006-3592, pages 2348 - 2358, XP071115329
OPPOSITION- Efren Pacis, Marcella Yu, Jennifer Autsen, Robert Bayer, Feng Li, "Effects of cell culture conditions on antibody N-linked glycosylation-what affects high mannose 5 glycoform", Biotechnology and Bioengineering, Wiley ¬etc.|, (20111001), vol. 108, no. 10, doi:10.1002/bit.23200, ISSN 00063592, pages 2348 - 2358, XP055080567
OPPOSITION- PACIS E. et al., "Effects of cell culture conditions on antibody N-linked gly- cosylation-what affects high mannose 5 glycoform", Biotechnol Bioeng., (20110000), vol. 108, pages 2348 - 2358, XP055080567
OPPOSITION- PACIS et al., "Effects of Cell Culture Conditions on Antibody N-linked Glycosylation - What Affects High Mannose 5 Glycoform", Biotechnol. Bioeng., (20110000), vol. 108, no. 1 0, doi:10.1002/bit.23200, pages 2348 - 2358, XP055080567
OPPOSITION- Surve Tanaya, Gadgil Mugdha, "Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: Implications for use of alternate sugars", Biotechnology Progress, American Chemical Society, (20150301), vol. 31, no. 2, doi:10.1002/btpr.2029, ISSN 8756-7938, pages 460 - 467, XP055927999
OPPOSITION- Maria Elisa Rodrigues, Costa Ana Rita, Henriques Mariana, Azeredo Joana, Oliveira Rosã¡rio, "Technological progresses in monoclonal antibody production systems", Biotechnology Progress, American Chemical Society, (20091230), vol. 26, doi:10.1002/btpr.348, ISSN 87567938, pages 332 - 351, XP055117107
OPPOSITION- Patrick Hossler, "Protein Glycosylation Control in Mammalian Cell Culture: Past Precedents and Contemporary Prospects", Advances in Biochemical Engineering Biotechnology, Springer, Berlin, Heidelberg , (20120101), vol. 127, pages 187 - 219, doi:10.1007/10_2011_113, ISBN 978-3-642-28349-9, XP055679442
OPPOSITION- Kuystermans, Al- Rubeai, "Antibody expression and production", Cell Engineering, (20110101), vol. 7, doi:10.1007/978-94-007-1257-7, pages 42 - 52, XP055951856
OPPOSITION- BIBILA T.A. et al., "In pursuit of the optimal fed-batch process for monoclonal antibody production", Biotechnol Prog, (19950000), vol. 11, no. 1, doi:10.1021/bp00031a001, pages 1 - 13, XP001183574
OPPOSITION- BOLLATI-FOGOLIN MARIELA ET AL, "Temperature reduction in cultures of hGM-CSF-expressing CHO cells: Effect on productivity and product quality", Biotechnology Progress, American Chemical Society, (20050101), vol. 21, no. 1, doi:10.1021/bp049825t, ISSN 8756-7938, pages 17 - 21, XP002461348
OPPOSITION- KAMINSKA JOANNA, GLICK MARY CATHERINE, KOSCIELAK JERZY, "Purification and characterization of GDP-L-Fuc: N-acetyl beta-D-glucosaminide alpha1 leads to 6fucosyltransferase from human blood platelets", Glycoconjugate Journal, Chapman & Hall, Boston, Boston , (19980801), vol. 15, no. 8, doi:10.1023/A:1006959915435, ISSN 0282-0080, pages 783 - 788, XP002526140
OPPOSITION- JENKINS N. et al., "Getting the glycosylation right: implications for the bio- technology industry", Nat Biotechnol., (19960000), vol. 14, pages 975 - 981, XP002133654
OPPOSITION- GONZALEZ DANIEL S ET AL, "Identification, expression, and characterization of a cDNA encoding human endoplasmic reticulum mannosidase I, the enzyme that catalyzes the first mannose trimming step in mammalian Asn-linked oligosaccharide biosynthesis.", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (19990723), vol. 274, no. 30, doi:10.1074/jbc.274.30.21375, ISSN 0021-9258, pages 21375 - 21386, XP002150706
OPPOSITION- HOSSLER P. et al., "Optimal and consistent protein glycosylation in mamma- lian cell culture", Glycobiology, (20090000), vol. 19, no. 9, pages 936 - 949, XP055112498
OPPOSITION- P. Hossler, S. F Khattak, Z. J. Li, "Optimal and consistent protein glycosylation in mammalian cell culture", Glycobiology, Oxford University Press, (20090901), vol. 19, no. 9, doi:10.1093/glycob/cwp079, ISSN 09596658, pages 936 - 949, XP055112498
OPPOSITION- A. M. Goetze, Y. D. Liu, Z. Zhang, B. Shah, E. Lee, P. V. Bondarenko, G. C. Flynn, "High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans", Glycobiology, Oxford University Press, (20110701), vol. 21, no. 7, doi:10.1093/glycob/cwr027, ISSN 09596658, pages 949 - 959, XP055169019
OPPOSITION- ARATHOON W R, BIRCH J R, "LARGE-SCALE CELL CULTURE IN BIOTECHNOLOGY", Science, American Association for the Advancement of Science, US, US , (19860101), vol. 232, no. 4756, doi:10.1126/science.2424083, ISSN 0036-8075, pages 1390 - 1395, XP008032746
OPPOSITION- Tojo S, Okazaki A, Wakitani M, Shinkawa T, Uchida K, Suzawa T., "A chromatographic approach for elevating the antibody-dependent cellular cytotoxicity of antibody composites.", Biological & pharmaceutical bulletin, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO., JP, JP , (20090901), vol. 32, no. 9, doi:10.1248/bpb.32.1604 , ISSN 0918-6158, pages 1604 - 1608, XP002689095
OPPOSITION- Feng Li, Natarajan Vijayasankaran, Amy (yijuan) Shen, Robert Kiss, Ashraf Amanullah, "Cell culture processes for monoclonal antibody production", mAbs, (20100901), vol. 2, no. 5, doi:10.4161/mabs.2.5.12720, ISSN 19420862, pages 466 - 479, XP055166177

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents